Q1 sees a lacklustre start to the year; 2024 outlook confirmed
24/04/24 -"Eurofins Scientific reported a Q1 2024 trading update slightly below the street’s expectations. While organic sales growth in the core business (excluding the COVID-19 related revenue and ..."
Pages
43
Language
English
Published on
24/04/24
You may also be interested by these reports :
01/05/24
Rentokil’s (Buy; UK) share price has been on a roller coaster ride since we last teased about it in March 2023. It fell sharply in October (c.15% in ...
26/04/24
SGS began the year with good organic growth in revenues, even though the yoy growth was heavily impacted by FX headwinds. Organic growth was higher ...
26/04/24
Bureau Veritas started the year with an organic growth beat vs. the company-compiled consensus, even though the absolute numbers were in line. FX was ...
24/04/24
Eurofins Scientific reported a Q1 2024 trading update slightly below the street’s expectations. While organic sales growth in the core business ...